. Human keratinocytes express both IL-la and IL-1, whereas only IL-la mRNA appears to be present in murine keratinocytes (6) . The production of this cytokine can be significantly enhanced either by chemical stimuli (7, 8) The FASEB Journal LEE Er AL. 
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MATERIALS AND METHODS
Materials
Statistical analysis
The statistical analysis of the data was performed by i-testand ANOVA using SPSS 4.0 (SPSS Inc., Chicago, Ill.). (Fig. l#{192}) . There was a significant increase in vascular permeability caused by IL-la at all doses tested (P < 0.05).
RESULTS
Vascular permeability
The dose-effect curve is shown in Fig. lB and was bellshaped with a maximum effect seen at 10 U to 100 jzU of IL-la.
A similar dose-response curve also has been reported 0 C IL-la 40 hr. Other mice were injected with PBS as a controland with anti-IL-la at times up to 2.5 h after TPA treatment. The photograph shows a representative skin from one of 12 mice in two separateexperiments.
A 1% salinesolutionof Evans blue dye at a dose of250 &l/30gbody weightwas injected intravenously in the tail 30 miii before death, which occurred 6 h afterTPA treatment. PBS or l0 U IL-ia in 50 t1PBS were injected intradermallyin the dorsal surfaceof animals at two different sites. The photomicrograph shows a representative section of 8 injection sites in 4 animals for each time point. The animals were killed 6 and 40 h afterinjection, and skin sectionswere fixed in formalin, processed by routine histological techniques, and 5 c sections were stained with hematoxylin and eosin. Sectionswere photographed at x 250 magnification. A) 6 h afterPBS controlinjection; B) 6 h after IL-la injection; and C) 40 h afterIL-la injection.
TPA begin 3 h after TPA treatment.
Anti The FASEB Journal LEE ET AL.
hyperplasia, IL-la was administered by untradermal injection in the dorsal surface of mice. Six hours after injection, significant increases in the number of cells in the dermal compartment were observed compared to IgG control injected skin (Fig. 3) . Furthermore, IL-la caused epidermal hyperplasia by 40 h after injection (Fig. 3) . The number of dermal cellswas determined by counting the cellsin a given area of the tissue,which isshown in Table 1 . The epidermal thickness and number of nucleated epidermal cells were determined and compared with that of control skin (Table 1 ). There was a significant increase (P < 0.001) in both hyperplasia and inflammatory cell infiltration by IL-la. The effectof anti-IL-ia antibody on TPA-induced hyperplasia and inflammatory cellinfiltration was also examined. The topical application of TPA (1 were still present in the dermal compartment of the skin 40 h after TPA treatment (Fig. 4) . Anti-IL-la antibody injected 5 mm before TPA treatment also reduced TPA-induced inflammatory cell infiltration as shown in Fig. 4 . There was a significant (P < 0.001) decrease, of approximately 79%, in TPA-induced dermal cell infiltration by anti-IL-Ia antibody (Table 2) . Intravenous injection of anti-IL-la antibody also reduced the hyperplasia induced by TPA; however, the effect appears to be nonspecific as intravenous injection of the control IgG produced the same effect (data not shown). (Fig. 5A) . Six hours after TPA treatment an increased number of inflammatory cells staining for IL-la was observed in the dermal compartment (Fig. 5B) . TPA treatment for 48 h caused a significant epidermal hyperplasia and the multiple layers of keratunocytes stained strongly for IL-ia (Fig. 5C') . Higher levels of IL-ia protein appear to be associated with suprabasal keratunocytes than with the basal layer of cells. a.
Immunohistochemistry
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